Thomas Reiser/LinkedIn
Dec 11, 2025, 23:36
Register for the ISTH Andexanet Research Recap
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), posted on LinkedIn:
”How do researchers evaluate the effects of andexanet in healthy volunteers and patients with acute major bleeding on enoxaparin?
Register for the upcoming International Society on Thrombosis and Haemostasis (ISTH) RPTH Journal Research Recap on
December 18 (17:00 UTC) with author Thijs van Haaps and Moderator Lara Roberts.”
Stay updated with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation